Mr. Neil Cohen's Insider Trades & SAST Disclosures

Mr. Neil Cohen's most recent trade in Chemomab Therapeutics Ltd - ADR was a trade of 5,172 Stock option (right to buy American Depositary Shares) done . Disclosure was reported to the exchange on Aug. 27, 2026.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 5,172 18,075 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 3,821 12,903 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 2,971 3,143 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 2,520 9,082 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 1,714 6,562 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 1,705 4,848 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Sale of securities on an exchange or to another person at price $ 2.85 per share. 27 Aug 2026 1,304 34,000 - 2.8 3,716 American Depositary Shares
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Sale of securities on an exchange or to another person at price $ 2.80 per share. 27 Aug 2026 1,000 33,000 - 2.8 2,800 American Depositary Shares
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director 27 Aug 2026 172 172 - - Stock option (right to buy American Depositary Shares)
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Sale of securities on an exchange or to another person at price $ 2.00 per share. 16 Nov 2022 2,409 10,000 - 2 4,818 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Sale of securities on an exchange or to another person at price $ 2.00 per share. 16 Nov 2022 2,409 10,000 - 2 4,818 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 3.19 per share. 18 May 2022 2,000 12,409 - 3.2 6,380 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 3.19 per share. 18 May 2022 2,000 12,409 - 3.2 6,380 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 4.20 per share. 14 Mar 2022 2,000 6,409 - 4.2 8,400 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 4.30 per share. 14 Mar 2022 2,000 8,409 - 4.3 8,600 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 4.56 per share. 14 Mar 2022 2,000 10,409 - 4.6 9,120 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 4.20 per share. 14 Mar 2022 2,000 6,409 - 4.2 8,400 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 4.30 per share. 14 Mar 2022 2,000 8,409 - 4.3 8,600 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 4.56 per share. 14 Mar 2022 2,000 10,409 - 4.6 9,120 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 7.43 per share. 06 Dec 2021 2,000 4,409 - 7.4 14,860 -
Chemomab Therapeutics Ltd (ADR)
Mr. Neil Cohen Director Purchase of securities on an exchange or from another person at price $ 7.43 per share. 06 Dec 2021 2,000 4,409 - 7.4 14,860 -
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades